Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
Department of Epidemiology and Health Statistics, West China School of Public Health, Sichuan University, Chengdu 610041, Sichuan Province, China.
World J Gastroenterol. 2020 Feb 21;26(7):740-748. doi: 10.3748/wjg.v26.i7.740.
The incidence of post-endoscopic retrograde cholangiopancreatography (ERCP) cholangitis (PEC) in patients who underwent mechanical lithotripsy (ML) for large stone removal is high (up to 13.3%). One of the main causes is remaining small fragments or sludge that can impair normal biliary drainage. Endoscopic placement of a nasobiliary tube or a conventional plastic biliary stent has been commonly used under such conditions, but the patient may suffer from significant discomfort after the placement of a nasobiliary tube, while additional endoscopy is required for stent removal. We developed a biliary spontaneous dislodgement spiral stent (BSDSS) to overcome those shortcomings.
To evaluate the feasibility, safety, and effectiveness of inserting a BSDSS for patients who underwent ML for large stone removal.
We conducted a single-center, retrospective, cohort study at West China Hospital, Sichuan University. A total of 91 consecutive patients with large biliary stones (≥ 10 mm) in the common bile duct who underwent ML between November 2017 and July 2018 were included. The 49 eligible patients were divided into the BSDSS group and the nasobiliary tube group. Technical success, post-ERCP adverse events (including PEC, post-ERCP pancreatitis, stone recurrence, BSDSS retention, self-extraction and dislocation of the nasobiliary tube), drainage time, and postoperative stay were measured and compared.
Twenty-one patients in the BSDSS group and 28 patients in the nasobiliary tube group were included in the analyses. The baseline characteristics and clinical information were similar in the two groups. Insertions of BSDSS and nasobiliary tube were technically successful in all 49 patients. There was no significant difference in the incidence of overall post-ERCP adverse events between the two groups (4.8% in the BSDSS group 17.9% in the nasobiliary tube group, = 0.219). The median duration of drainage time (3 d in the BSDSS group 4 d in the nasobiliary tube group) and length of postoperative stay (4 d in the BSDSS group 5 d in the nasobiliary tube group) also did not differ ( = 0.934, and = 0.223, respectively).
Endoscopic placement of a BSDSS appears to be feasible, safe and effective for patients who underwent ML for large stone removal.
接受机械碎石术(ML)取大结石的患者,发生内镜逆行胰胆管造影(ERCP)后胆管炎(PEC)的发生率较高(高达 13.3%)。其中一个主要原因是存在小碎片或淤泥,可能会影响正常的胆汁引流。在这种情况下,通常会使用内镜下放置鼻胆管或传统的塑料胆管支架,但放置鼻胆管后患者会感到明显不适,而支架需要再次进行内镜取出。我们开发了一种胆道自发移位螺旋支架(BSDSS)来克服这些缺点。
评估 BSDSS 用于接受 ML 取大结石的患者的可行性、安全性和有效性。
我们在四川大学华西医院进行了一项单中心、回顾性、队列研究。共纳入 2017 年 11 月至 2018 年 7 月间接受 ML 治疗的 91 例胆总管大结石(≥10mm)患者。其中 49 例符合条件的患者被分为 BSDSS 组和鼻胆管组。测量并比较了技术成功率、ERCP 后不良事件(包括 PEC、ERCP 后胰腺炎、结石复发、BSDSS 留置、自行拔出和鼻胆管移位)、引流时间和术后住院时间。
BSDSS 组 21 例,鼻胆管组 28 例患者纳入分析。两组患者的基线特征和临床资料相似。所有 49 例患者均成功插入 BSDSS 和鼻胆管。两组总体 ERCP 后不良事件发生率无显著差异(BSDSS 组为 4.8%,鼻胆管组为 17.9%, = 0.219)。BSDSS 组引流时间(3 天)和术后住院时间(4 天)中位数均短于鼻胆管组(4 天),但差异无统计学意义( = 0.934, = 0.223)。
对于接受 ML 取大结石的患者,内镜下放置 BSDSS 似乎是可行、安全且有效的。